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International Perspectives on Hospice and Palliative Care
for HIV/AIDS
S.R. Connor
National Hospice and Palliative Care Organization,
Alexandria, VA, USA
Hospice and palliative care is an essential component of
the continuum of care for people living with HIV/AIDS.
There is considerable symptom burden associated with
HIV/AIDS throughout the course of the illness and palliative
care is valuable both in optimizing functioning as well as
at the end of life. In this presentation we will explore
the extent of the need for palliative care in HIV/AIDS, the
problems that are responsive to palliative care, the range of
available palliative interventions, and how palliative care
can be incorporated into ongoing anti-retroviral therapies.
We will examine the differences between supportive and
palliative care as well as the public health implications for
palliative care. Where ever possible palliative care must
not be a substitute for active disease therapy. Appropriate
palliative care as deﬁned by WHO, must include impeccable
assessment and treatment of pain and other symptoms
using an interdisciplinary team skilled in addressing all
the dimensions of the human experience for PLWHVA’s and
those who care for them.
doi:10.1016/j.ijid.2008.05.134
56.002
Clinical Issues in Palliative Care for HIV/AIDS
E. Hamzah
Hospis Malaysia, Kuala Lumpur, Malaysia
Over the past 40 years, palliative care has made inroads in
healthcare services. Although it has its roots in the care of
the dying and advanced cancer, it is slowly making an impact
in the struggle against HIV/AIDS.
Clinical issues in dealing with HIV/AIDs needs to be con-
sidered along with the psychosocial, cultural, ethical and
speciﬁc nature of the HIV/AIDS illness. The myriad of symp-
toms that may present in a patient needs to be individualised
and take into account the resources available, the desired
outcomes and whether the patient is in a hospital or com-
munity setting. The aim is to minimise the symptom load to
improve the quality of life but palliative care services need
to be tailored to the ﬂuctuations of the disease as well as
consider the possible reversibility of associated conditions.
In the setting of providing palliative care for HIV/AIDS
in developing countries, much of the suffering of such
patients could be addressed by integrating palliative care
into the disease management programme of current service
provision. Palliative Care complements the other medical
treatments and with a holistic approach could assist those
with controlled illness but also with those with advanced
and dying of the illness.
doi:10.1016/j.ijid.2008.05.135
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uccessful Development in Hospice and Palliative Care in
sia
.R. Goh
Lien Centre for Palliative Care, Singapore, Singapore
ospice and Palliative Care services in Asia developed in
he more economically developed countries in the 1980s.
ountries like Japan, South Korea, Taiwan, Hong Kong and
ingapore have relatively well developed palliaitve care ser-
ices. In the 1990s services started developing in Malaysia,
ndonesia and the Philippines, and good progress has been
ade in various centres in these countries, though over-
ll coverage still needs to be improved. The Asia Paciﬁc
ospice Palliative Care Network is a regional network of
ndividuals and organizations which act as a resource for
alliative care. Faculty from established palliative care ser-
ices travel to resource-poor countries to help train trainers
t the invitation of local organizations. One such project
s in Vietnam where a 3-year Training of Trainers project
rganized by the Singapore International Foundation pro-
ided training in two palliative care units in Ho Chi Minh
ity and Hanoi in Vietnam. Together with simultaneous
fforts by the Vietnam-CDC-Harvard group to provide a
ational Palliative Care Program for Vietnam, palliative care
ervices for both cancer and HIV patients have been devel-
ped, and Vietnam is in the process of establishing its own
ational Association for Palliative Care. A further exam-
le of palliative care development in Thailand will also be
resented.
oi:10.1016/j.ijid.2008.05.136
6.004
ational and International Measurement Opportunities
. Casarett1,∗, S. Connor2
University of Pennsylvania, Philadelphia, PA, USA
National Hospice and Palliative Care Organization,
lexandria, VA, USA
he growing ﬁeld of hospice and palliative care has been pro-
oted most effectively in industrialized countries, where it
as focused primarily on chronic illnesses such as cancer.
owever, in underdeveloped countries, HIV/AIDS repre-
ents a major public health problem. Despite aggressive
revention efforts and growing access to antiretrovirals,
IV/AIDS remains a fatal disease for many people. There-
ore, there is growing international interest in applying
rinciples of hospice and palliative care to improve the
are that patients with HIV/AIDS receive near the end
f life.
This symposium will provide an overview of worldwide
ospice and palliative care efforts in HIV/AIDS, identify-
ng key opportunities and challenges. First, presenters will
escribe common palliative care needs in this population,
ncluding estimates of the prevalence of pain and other
ymptoms. Next, presenters will trace the growth and devel-
pment of HIV/AIDS-focused efforts to provide hospice and
alliative care in resource-poor settings. Finally, presenters
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ill describe two case studies of successful HIV/AIDS hospice
rograms in Southeast Asia.
oi:10.1016/j.ijid.2008.05.137
merging Infections: What Have We Learned After
5 Years? (invited)
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merging Infections: What Have We Learned After
5 Years?
. Heymann
WHO, Geneva, Switzerland
nfectious diseases are complex, dynamic, and constantly
volving. Examples during the past 15 years range from
hanges in transmission patterns of human monkeypox
nd dengue; more frequent re-emergence of cholera,
egionnaire’s disease, E. coli 0157, hepatitis C and, the
aemorrhagic fevers - Marburg, Lassa and Ebola; and emer-
ence of bovine spongiform encephalopathy (BSE), severe
cute respiratory syndrome (SARS) and H5N1 inﬂuenza.
Causes of emergence and re-emergence include weak-
ned public health infrastructure, increases in human
nd domestic animal populations, rapid urbanization, and
ffects on the environment from global warming to defor-
station and ﬂooding. Human behavior also plays a major
ole, ranging from unsafe sexual practices to over- or
nder-prescribing of antimicrobial drugs, patient adher-
nce, unregulated sale, and indiscriminate use in humans,
lants and animals.
Emerging and re-emerging infections occur in a world
here international travel and trade facilitate their spread,
nd where their impact affects economies as well as health.
ttempts at regulation to prevent their international spread
ccurred ﬁrst in the 14th century quarantines in Venice.
hey continued during the 19th and 20th centuries in Europe
nd the Americas through a series of conferences and con-
entions leading to the International Health Regulations.
he goal of the Regulations is to strengthen national capac-
ties to detect and respond to emerging or re-emerging
nfections when and where they occur, with the guarantee
f a safety net of collective detection and response should
hey cross international borders.
The lesson over the past 15 years - whether from
he global response to SARS or preparations for the next
nﬂuenza pandemic - is that collective action will decrease
ur vulnerability, and increase our public health security.
he challenge is to ensure resources for our collective action
nder the framework of the International Health Regula-
ions.
oi:10.1016/j.ijid.2008.05.138
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ow to Evaluate Response to Treatment in AOM
.P. McCormick
University of Texas Medical Branch at Galveston, Galveston,
X, USA
ackground: Several studies have shown that watchful wait-
ng management of acute otitis media (AOM) can be an
lternative to immediate antibiotics. In practice, clinicians
ay be more comfortable using the watchful waiting option
hen the child has mild symptoms and the ear is not severely
nﬂamed. Regarding clinical trials, standardized criteria for
he diagnosis of AOM, and a clear description of TM ﬁnd-
ngs has often been lacking, making interpretation of study
esults somewhat difﬁcult. The objective of this paper will
e to deﬁne AOM, review the development of an Ear Card
ethodology for assessing the child with AOM, and describe
he effective use of the Ear Card in a clinical trial.
Methods: The Ear Card system for assessing the child with
OM was evaluated for concurrent correlation, sequence
alidity and reliability against previously published question-
aires. Responsiveness was assessed during a randomized
linical trial.
Results: The system demonstrated excellent sequence
alidity, concurrent correlation and reliability.
Conclusions: The Ear Card combines a parent assessment
f severity using a faces scale and the clinician’s assessment
f the tympanic membrane to provide an evaluation of total
OM severity that can be used to characterize AOM signs and
ymptoms at enrollment and to evaluate a patients progress
uring treatment. For research, clinical investigators can be
eliably trained using the Ear Card, so that clinical charac-
eristics at enrollment and follow-up can be clearly deﬁned
nd scored. The method is sufﬁciently sensitive to detect
mall differences in outcomes between treatment groups.
he Ear Card has also been useful in teaching residents and
tudents to accurately assess the tympanic membrane.
Clinicians, AOM researchers, and clinical educators from
round the world have requested our copyrighted electronic
ersion of the Ear Card, which may be freely used for patient
are, teaching and research.
oi:10.1016/j.ijid.2008.05.139
9.002
ummary of Studies With New Antibiotics in AOM in Last
ecade - Where Are We?
. Arguedas
Instituto de Atención Pediátrica, San Jose, Costa Rica
n the last decade multiple clinical antimicrobials with new
ntibiotics have been performed in children. During this
ime, the design of the clinical trial improved dramati-
ally to take into consideration multiple factors but always
eeping as the most critical factor the resolution of signs
nd symptoms from the participant children. In this regard,
rial have taking into consideration the use of innovative
